Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | XXII 22nd Century Group, Inc | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.85 +1.0% | $15.90 -2.5% |
| StockIQ Score | 42D Weak Risk: Medium | 41D Weak Risk: High |
| Technical | 12F | 36F |
| Fundamental | 39F | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 55C | 38F |
| News | 44D | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
22nd Century Group (XXII) outperforms Ascentage Pharma (AAPG) in growth (68 vs. 50) and valuation (55 vs. 38), showing stronger potential in these areas. However, AAPG has a slightly better investor score (41 vs. 42) and higher technical score (36 vs. 12), indicating more favorable market activity and technical health. Both carry a "WEAK" rating, but XXII’s higher growth and valuation scores make it relatively stronger in those categories.
